Get More Information on Blood Group Typing Market - Request Sample Report
The Blood Group Typing Market was estimated at USD 1.9 billion in 2023 and is poised to reach 4.05 billion in 2032 anticipated to expand at a compound annual growth rate of 8.8% for the forecast period of 2024-2032.
A growing number of blood transfusions due to an increase in traffic accidents, rising blood transfusion rates, and expanding demand for blood and associated goods are some of the reasons anticipated to support development. Prior to blood transfusions, blood group typing is a required test that determines the Rh factor as well as the degree of blood compatibility between the donor and the recipient. The market is expected to continue to expand as a result of increasing utilisation of these tests for the diagnosis of Haemolytic Disease of the Newborn (HDN). Major biotechnology and healthcare businesses involved in this sector concentrate on creating cutting-edge tools and products for identifying blood group types at the molecular level. For instance, the blood banks employ the adaptable DNA microarray technology that enables the processing of genotypes and blood samples for thorough screening at affordable pricing.
Additionally, businesses are putting more and more effort into creating technologies that can effectively handle the burden associated with blood tests. For instance, the Food and Drug Administration (FDA) approved Immucor's Precise Type HEA test in November 2016 for use in the identification of sickle cell characteristics in blood donors. National rules for ensuring everyone has access to safe blood are being developed and implemented by a number of regulatory organisations, including the FDA. Additionally, researchers are working on sensitive donor screening methods to identify possible bioterrorism agents and potentially emerging illnesses in blood donations. Ample blood stocks are also being prepared by the FDA and other American government agencies and organisations in case of crises. The primary factor influencing the market for blood group typing may be attributed to an increase in such government activities related to blood safety.
DRIVERS
Rising need for organ transplants and blood transfusions.
Increasing understanding of and significance of personalised medicine.
External funding for the clinical studies aimed at developing new and advanced technology in diagnostics tests is a major driver to the growth of the market. Rising awareness among patients about types of self-testing and home diagnostics tests is likely to influence the growth of the global blood testing market. Continuously increasing prevalence of chronic, diseases long with a rapid growth in the demand for fast products for accessing health problem is projected to propel the market in the coming years.
RESTRAINS
The high cost of blood group typing tests.
little knowledge and infrastructure in certain areas.
Lack of awareness about latest technology devices among patient in the developing countries such as India, Indonesia, Malaysia is expected to hinder the market growth during the forecast period. High cost of the devices and self-testing kits is likely to be a Factors restraining the market demand in the coming years.
OPPORTUNITIES
More people are requesting pre-transfusion testing.
An increase in prenatal testing demand.
Blood group typing market prospects are presented by the increased number of blood transfusions, which is caused by an ageing population, trauma cases, and surgical operations. In order to determine any potential incompatibility between the mother and foetus, blood group typing is crucial in prenatal treatment. Opportunities for blood group typing tests in this market area are provided by the growing emphasis on prenatal diagnosis. Because of the expanding need for personalised medication, increased disposable income, and improved healthcare infrastructure in emerging nations, the blood group typing industry has great development potential.
CHALLENGES
Strict regulatory standards limited access to skilled workers.
Cultural aspects and ethical issues.
To guarantee accuracy and safety, blood group typing tests must adhere to strict regulatory criteria. For market participants, especially smaller businesses, complying with these requirements can be difficult. Blood group typing tests need to be performed by qualified professionals who can manage and correctly interpret the data. The expansion of the market may be hampered by a lack of qualified workers in some areas. The use of genetic information in blood group typing may give rise to ethical questions or cultural sensitivities in particular populations or geographical areas. The ability to comprehend and handle these issues is essential for market penetration.
As a result of the conflict and tensions between Russia and Ukraine, it may be more difficult to get the medical supplies, reagents, and other materials needed for blood-type typing tests. Testing delays, shortages, or greater prices for market participants might result from this interruption. The protracted conflict may cause strain on Ukraine's healthcare system, limiting the availability of medical services including blood type typing testing. This may have an effect on the market's ability to meet the demand for these tests. Regional demography may change as a result of population movement and displacement brought on by the conflict. As the distribution of blood types may differ among populations, these demographic shifts may have an influence on the demand for blood group typing tests in various locations.
IMPACT OF ONGOING RECESSION
Due to financial restrictions, people and governments frequently cut back on healthcare spending during a recession. The need for unnecessary medical testing, such as blood type typing, may decrease as a result. The market for blood group typing tests may see a decline in sales as a result. People may put off or skip elective medical treatments, such as blood group typing testing, during difficult economic times. Prioritizing important healthcare treatments may allow patients to postpone less urgent testing until their financial position has improved. This can cause the demand for blood group typing services to momentarily fall.
By Product
Consumables
Instruments
Services
By Technique
PCR-based and Microarray Techniques
Assay-based Techniques
Massively Parallel Sequencing Techniques
Other Techniques
By Test Type
Antibody Screening
Cross-matching Tests
ABO Blood Tests
Antigen Typing
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
South Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of the Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin American
North America
Due to an increase in transfusions in high-income nations like the U.S., North America held the greatest market share in 2023. Data from the World Health Organisation (WHO) show that 42% of blood donations in 2019 came from high-income nations. In the United States, there were around 18 million prenatal visits in 2015, according to the Centres for Disease Control and Prevention (CDC). The need for blood group typing during prenatal testing is boosted as a result. Additionally, market participants launching new products by the major industry players are anticipated to support regional growth.
Asia Pacific
An increasing incidence of chronic conditions necessitating blood group typing is expected to cause Asia Pacific to grow at the quickest rate throughout the projection period. Growing worry over the prevalence of infectious diseases in this area is what's fuelling industrial expansion. Additionally, the adoption of these tests in the area is anticipated to be sparked by the rising number of trauma cases and traffic accidents in nations like India.
Get Customized Report as per Your Business Requirement - Request For Customized Report
The major key players are Grifols, S.A, Merck KGaA, Bio-Rad Laboratories, Inc., Immucor, Inc., Novacyt Group, Danaher Corporation, Agena Bioscience, Inc, Ortho Clinical Diagnostics, Quotient. Ltd, Bio-Rad Laboratories, Inc, Quidelortho and others.
Grifols:
Grifols announced a partnership with Endpoint Health, Inc. in February 2022 to commercialise and create an Antithrombin III (AT-III) drug to treat sepsis. Endpoint Health, Inc. is a pharmaceutical firm focusing on addressing important issues in immune-driven critical care.
Ortho Clinical:
Quidel Corporation and Ortho Clinical Diagnostics Holdings plc joined forces in May 2022 to become QuidelOrtho, a well-known brand in the IVD industry.
| Report Attributes | Details |
| Market Size in 2023 | US$ 1.9 Bn |
| Market Size by 2032 | US$ 4.05 Bn |
| CAGR | CAGR of 8.8% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Consumables, Instruments, Services) • By Technique (PCR-based and Microarray Techniques, Assay-based Techniques, Massively Parallel Sequencing Techniques, Other Techniques) • By Test Type (Antibody Screening, HLA Typing, Cross-matching Tests, ABO Blood Tests, Antigen Typing) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Grifols, S.A, Merck KGaA, Bio-Rad Laboratories, Inc., Immucor, Inc., Novacyt Group, Danaher Corporation, Agena Bioscience, Inc, Ortho Clinical Diagnostics, Quotient. Ltd, Bio-Rad Laboratories, Inc, Quidelortho |
| Key Drivers | • Rising need for organ transplants and blood transfusions. • Increasing understanding of and significance of personalized medicine. |
| Market Opportunities | • More people are requesting pre-transfusion testing. • An increase in prenatal testing demand. |
Ans: The CAGR Growth rate of the Blood Group Typing Market is approx. CAGR 8.8% for the forecast period of 2024-2032.
Ans: The projected market size of Blood Group Typing Market at USD 1.9 billion in 2023 and is poised to reach 4.05 billion in 2032
Ans: The major key players are Grifols, S.A, Merck KGaA, Bio-Rad Laboratories, Inc., Immucor, Inc., Novacyt Group, Danaher Corporation, Agena Bioscience, Inc, Ortho Clinical Diagnostics, Quotient. Ltd, Bio-Rad Laboratories, Inc, Quidelortho and others.
Ans: Key competitors in the worldwide blood testing market are concentrating on developing and introducing their goods in novel and innovative methods to better serve the end consumers. Utilising cutting-edge technology, such artificial intelligence, to identify correct results at an early stage of a disease is benefiting the end users.
Ans: North America accounted for over 30% of global business in 2023 and will continue to expand as a result of the region's strong industrial presence, high healthcare expenditure, and regulatory approvals of cutting-edge technology.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of the Ukraine- Russia war
4.2 Impact of ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.22.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Blood Group Typing Market, By Product
8.1 Consumables
8.2 Instruments
8.3 Services
9. Blood Group Typing Market By Technique
9.1 PCR-based and Microarray Techniques
9.2 Assay-based Techniques
9.3 Massively Parallel Sequencing Techniques
9.4 Other Techniques
10. Blood Group Typing Market, By Test Type
10.1 Antibody Screening
10.2 HLA Typing
10.3 Cross-matching Tests
10.4 ABO Blood Tests
10.5 Antigen Typing
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 North America Blood Group Typing Market by Country
11.2.2North America Blood Group Typing Market By Product
11.2.3 North America Blood Group Typing Market By Technique
11.2.4 North America Blood Group Typing Market By Test Type
11.2.5 USA
11.2.5.1 USA Blood Group Typing Market By Product
11.2.5.2 USA Blood Group Typing Market By Technique
11.2.5.3 USA Blood Group Typing Market By Test Type
11.2.6 Canada
11.2.6.1 Canada Blood Group Typing Market By Product
11.2.6.2 Canada Blood Group Typing Market By Technique
11.2.6.3 Canada Blood Group Typing Market By Test Type
11.2.7 Mexico
11.2.7.1 Mexico Blood Group Typing Market By Product
11.2.7.2 Mexico Blood Group Typing Market By Technique
11.2.7.3 Mexico Blood Group Typing Market By Test Type
11.8 Europe
11.8.1 Europe Blood Group Typing Market by Country
11.8.2 Europe Blood Group Typing Market By Product
11.8.3 Europe Blood Group Typing Market By Technique
11.8.4 Europe Blood Group Typing Market By Test Type
11.8.6 Germany
11.8.6.1 Germany Blood Group Typing Market By Product
11.8.6.2 Germany Blood Group Typing Market By Technique
11.8.6.3 Germany Blood Group Typing Market By Test Type
11.8.7 UK
11.8.7.1 UK Blood Group Typing Market By Product
11.8.7.2 UK Blood Group Typing Market By Technique
11.8.7.3 UK Blood Group Typing Market By Test Type
11.8.8 France
11.8.8.1 France Blood Group Typing Market By Product
11.8.8.2 France Blood Group Typing Market By Technique
11.8.8.3 France Blood Group Typing Market By Test Type
11.9.9 Italy
11.3.9.1 Italy Blood Group Typing Market By Product
11.3.9.2 Italy Blood Group Typing Market By Technique
11.3.9.3 Italy Blood Group Typing Market By Test Type
11.3.10 Spain
11.3.10.1 Spain Blood Group Typing Market By Product
11.3.10.2 Spain Blood Group Typing Market By Technique
11.3.10.3 Spain Blood Group Typing Market By Test Type
11.3.11 The Netherlands
11.3.11.1 Netherlands Blood Group Typing Market By Product
11.3.11.2 Netherlands Blood Group Typing Market By Technique
11.3.11.3 Netherlands Blood Group Typing Market By Test Type
11.3.11 Rest of Europe
11.3.11.1 Rest of Europe Blood Group Typing Market By Product
11.3.11.2 Rest of Europe Blood Group Typing Market By Technique
11.3.11.3 Rest of Europe Blood Group Typing Market By Test Type
11.4 Asia-Pacific
11.4.1 Asia Pacific Blood Group Typing Market by Country
11.4.2 Asia Pacific Blood Group Typing Market By Product
11.4.3 Asia Pacific Blood Group Typing Market By Technique
11.4.4Asia Pacific Blood Group Typing Market By Test Type
11.4.6 Japan
11.4.6.1 Japan Blood Group Typing Market By Product
11.4.6.2 Japan Blood Group Typing Market By Technique
11.4.6.3 Japan Blood Group Typing Market By Test Type
11.4.7 South Korea
11.4.7.1 South Korea Blood Group Typing Market By Product
11.4.7.2 South Korea Blood Group Typing Market By Technique
11.4.7.3 South Korea Blood Group Typing Market By Test Type
11.4.8 China
11.4.8.1 China Blood Group Typing Market By Product
11.4.8.2 China Blood Group Typing Market By Technique
11.4.8.3 China Blood Group Typing Market By Test Type
11.4.9 India
11.4.9.1 India Blood Group Typing Market By Product
11.4.9.2 India Blood Group Typing Market By Technique
11.4.9.3 India Blood Group Typing Market By Test Type
11.4.10 Australia
11.4.10.1 Australia Blood Group Typing Market By Product
11.4.10.2 Australia Blood Group Typing Market By Technique
11.4.10.3 Australia Blood Group Typing Market By Test Type
11.4.11 Rest of Asia-Pacific
11.4.11.1 APAC Blood Group Typing Market By Product
11.4.11.2 APAC Blood Group Typing Market By Technique
11.4.11.3 APAC Blood Group Typing Market By Test Type
11.5 The Middle East & Africa
11.5.1 The Middle East & Africa Blood Group Typing Market by Country
11.5.2 The Middle East & Africa Blood Group Typing Market By Product
11.5.3 The Middle East & Africa Blood Group Typing Market By Technique
11.5.4The Middle East & Africa Blood Group Typing Market By Test Type
11.5.6 Israel
11.5.6.1 Israel Blood Group Typing Market By Product
11.5.6.2 Israel Blood Group Typing Market By Test Type
11.5.6.3 Israel Blood Group Typing Market By Technique
11.5.7 UAE11.5.7.1 UAE Blood Group Typing Market By Product
11.5.7.2 UAE Blood Group Typing Market By Technique
11.5.7.3 UAE Blood Group Typing Market By Test Type
11.5.8 South Africa
11.5.8.1 South Africa Blood Group Typing Market By Product
11.5.8.2 South Africa Blood Group Typing Market By Technique
11.5.8.3 South Africa Blood Group Typing Market By Test Type
11.5.9 Rest of Middle East & Africa
11.5.9.1 Rest of Middle East & Asia Blood Group Typing Market By Product
11.5.9.2 Rest of Middle East & Asia Blood Group Typing Market By Technique
11.5.9.3 Rest of Middle East & Asia Blood Group Typing Market By Test Type
11.6 Latin America
11.6.1 Latin America Blood Group Typing Market by Country
11.6.2 Latin America Blood Group Typing Market By Product
11.6.3 Latin America Blood Group Typing Market By Technique
11.6.4 Latin America Blood Group Typing Market By Test Type
11.6.6 Brazil11.6.6.1 Brazil Blood Group Typing Market By Product
11.6.6.2 Brazil Africa Blood Group Typing Market By Technique
11.6.6.3Brazil Blood Group Typing Market By Test Type
11.6.7 Argentina
11.6.7.1 Argentina Blood Group Typing Market By Product
11.6.7.2 Argentina Blood Group Typing Market By Technique
11.6.7.3 Argentina Blood Group Typing Market By Test Type
11.6.8 Rest of Latin America
11.6.8.1 Rest of Latin America Blood Group Typing Market By Product
11.6.8.2 Rest of Latin America Blood Group Typing Market By Technique
11.6.8.3 Rest of Latin America Blood Group Typing Market By Test Type
12. Company profile
12.1 Grifols
12.1.1 Market Overview
12.1.2 Financials
12.1.3 Treatment/End-User/Offerings
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 Merck KGaA.
12.2.1 Market Overview
12.2.2 Financials
12.2.3 Treatment/End-User/Offerings
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 Bio-Rad Laboratories, Inc.
12.3.1 Market Overview
12.3.2 Financials
12.3.3 Treatment/End-User/Offerings
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 Immucor, Inc.
12.4.1 Market Overview
12.4.2 Financials
12.4.3 Treatment/End-User/Offerings
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 Novacyt Group.
12.5.1 Market Overview
12.5.2 Financials
12.5.3 Treatment/End-User/Offerings
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 Danaher Corporation.
12.6.1 Market Overview
12.6.2 Financials
12.6.3 Treatment/End-User/Offerings
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 Agena Bioscience, Inc,
12.7.1 Market Overview
12.7.2 Financials
12.7.3 Treatment/End-User/Offerings
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 Ortho Clinical Diagnostics.
12.8.2 Financials
12.8.3 Treatment/End-User/Offerings
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 Quotient. Ltd.
12.9.1 Market Overview
12.9.2 Financials
12.9.3 Treatment/End-User/Offerings
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 Bio-Rad Laboratories, Inc.
12.10.1 Market Overview
12.10.2 Financials
12.10.3 Treatment/End-User/Offerings
12.10.4 SWOT Analysis
12.10.5 The SNS View
13. Competitive Landscape
13.1 Competitive Benchmarking
13.2 Market Share Analysis
13.3 Recent Developments
14. Use Case and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Cosmeceuticals Market Size was valued at USD 63.63 Billion in 2023, and is expected to reach USD 142.52 Billion by 2032, and grow at a CAGR of 9.84%.
The Diabetic Neuropathy Market Size was valued at USD 4.36 billion in 2023 and is witnessed to reach USD 8.38 billion by 2032 and grow at a CAGR of 7.81% over the forecast period 2024-2032.
The Plasma Therapy Market was valued at USD 417.0 Mn in 2023 and is expected to reach USD 1087.0 Mn by 2032 and grow at a CAGR of 11.25% from 2024 to 2032.
The Multiple Sclerosis (MS) Market size was valued at USD 21.5 billion in 2023 and is expected to reach USD 39.20 billion by 2031 and grow at a CAGR of 7.8% over the forecast period of 2024-2031.
The Hyperphosphatemia Treatment Market Size was valued at USD 1.33 billion in 2023, and is expected to reach USD 2.73 billion by 2032, and grow at a CAGR of 8.3% over the forecast period 2024-2032.
The Recombinant Vaccines Market Size was valued at USD 12.53 Billion in 2023, and is expected to reach USD 32.83 Billion by 2032, and grow at a CAGR of 11.88%.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
